Yes. The only information I found on earlier testing was the following
The potential therapeutic was studied thoroughly and showed safety and efficacy in preclinical and IND-enabling studies.
https://www.cureraredisease.org/blog-posts/faq-on-the-findings-from-the-crd-tmh-001-case-report
Ann: PYC Therapeutics Investor Call - 18 August 2022, page-25
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $171.4K | 908.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20638 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 243328 | 9 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |